Candida albicans: A Model Organism for Studying Fungal Pathogens
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Candida albicans is an opportunistic human fungal pathogen that causes candidiasis. As healthcare has been improved worldwide, the number of immunocompromised patients has been increased to a greater extent and they are highly susceptible to various pathogenic microbes and C. albicans has been prominent among the fungal pathogens. The complete genome sequence of this pathogen is now available and has been extremely useful for the identification of repertoire of genes present in this pathogen. The major challenge is now to assign the functions to these genes of which 13% are specific to C. albicans. Due to its close relationship with yeast Saccharomyces cerevisiae, an edge over other fungal pathogens because most of the technologies can be directly transferred to C. albicans from S. cerevisiae and it is amenable to mutation, gene disruption, and transformation. The last two decades have witnessed enormous amount of research activities on this pathogen that leads to the understanding of host-parasite interaction, infections, and disease propagation. Clearly,C. albicans has emerged as a model organism for studying fungal pathogens along with other two fungi Aspergillus fumigatus and Cryptococcus neoformans. Understanding its complete life style of C. albicans will undoubtedly be useful for developing potential antifungal drugs and tackling Candida infections. This will also shed light on the functioning of other fungal pathogens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
RNA-Seq: a revolutionary tool for transcriptomics
Wang, Z., Gerstein, M., & Snyder, M. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2484 · Cited by 13,174 · cited 1×
“Subsequently, each cDNA molecule is sequenced by high-throughput sequencing technology to obtain short sequences of sizes ranging from 30 to 400 bp depending upon the sequencing technology used [21].”
MethodHigh-Resolution Profiling of Histone Methylations in the Human Genome
Barski, A., Cuddapah, S., Cui, K., Roh, T.-Y., Schones, D. E., Wang, Z., Wei, G., Chepelev, I., & Zhao, K. (2007) · Cell · doi:10.1016/j.cell.2007.05.009 · Cited by 6,845 · cited 1×
“Purified DNA can be subjected to direct high-throughput sequencing (ChIP-seq) to determine the exact sequence of the DNA present in the immunoprecipitated chromatin [45].”
BackgroundBiofilms: Survival Mechanisms of Clinically Relevant Microorganisms
Donlan, R. M., & Costerton, J. W. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.167-193.2002 · Cited by 6,644 · cited 1×
“One of the most important manifestations of biofilm formation is their high-level drug resistance to different antifungal drugs [114, 123, 124].”
BackgroundEpidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174 · cited 1×
“Systemic Candida infections are common to immunocompromised individuals, including HIV-infected patients, transplant recipients, chemotherapy patients, and low-birth weight infants [9, 10].”
BackgroundThe Transcriptional Landscape of the Yeast Genome Defined by RNA Sequencing
Nagalakshmi, U., Wang, Z., Waern, K., Shou, C., Raha, D., Gerstein, M., & Snyder, M. (2008) · Science · doi:10.1126/science.1158441 · Cited by 2,479
Nonfilamentous C. albicans Mutants Are Avirulent
Lo, H.-J., Köhler, J. R., DiDomenico, B., Loebenberg, D., Cacciapuoti, A., & Fink, G. R. (1997) · Cell · doi:10.1016/s0092-8674(00)80358-x · Cited by 1,809
Chandra, J., Kuhn, D. M., Mukherjee, P. K., Hoyer, L. L., McCormick, T., & Ghannoum, M. A. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.18.5385-5394.2001 · Cited by 1,578 · cited 1×
“Then, with further secretion, biofilms will be covered by extracellular matrix which is mainly composed of carbohydrates and proteins [114, 116, 117].”
BackgroundGenomic sequence of the pathogenic and allergenic filamentous fungus Aspergillus fumigatus
Nierman, W. C., Pain, A., Anderson, M. J., Wortman, J. R., Kim, H. S., Arroyo, J., Berriman, M., Abe, K., Archer, D. B., Bermejo, C., et al. (2005) · Nature · doi:10.1038/nature04332 · Cited by 1,391
Virulence factors of Candida albicans
Calderone, R. A., & Fonzi, W. A. (2001) · Trends in Microbiology · doi:10.1016/s0966-842x(01)02094-7 · Cited by 1,331 · cited 2×
“[178] R.”
BackgroundCandida albicans Secreted Aspartyl Proteinases in Virulence and Pathogenesis
Naglik, J. R., Challacombe, S. J., & Hube, B. (2003) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.67.3.400-428.2003 · Cited by 1,179 · cited 1×
“The role of these SAPs in pathogenicity has been deduced from the observations that they are secreted in vivo during infection, the enzymes have the ability to degrade a number of important host factors, and the mutant strains have reduced virulence [167, 179, 180].”
BackgroundA Global Map of p53 Transcription-Factor Binding Sites in the Human Genome
Wei, C.-L., Wu, Q., Vega, V. B., Chiu, K. P., Ng, P., Zhang, T., Shahab, A., Yong, H. C., Fu, Y., Weng, Z., et al. (2006) · Cell · doi:10.1016/j.cell.2005.10.043 · Cited by 1,141 · cited 1×
“DNA can also be cloned into plasmid vectors and then sequencing can be performed [46, 47].”
BackgroundAttributable Mortality of Nosocomial Candidemia, Revisited
Gudlaugsson, O., Gillespie, S., Lee, K., Berg, J. V., Hu, J., Messer, S., Herwaldt, L., Pfaller, M., & Diekema, D. (2003) · Clinical Infectious Diseases · doi:10.1086/378745 · Cited by 1,140
Growth of Candida albicans hyphae
Sudbery, P. E. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2636 · Cited by 1,110 · cited 1×
“albicans has the ability to grow as unicellular budding yeast or filamentous form of hyphae or pseudohyphae [186].”
BackgroundEvolution of pathogenicity and sexual reproduction in eight Candida genomes
Butler, G., Rasmussen, M. D., Lin, M. F., Santos, M. A. S., Sakthikumar, S., Munro, C. A., Rheinbay, E., Grabherr, M., Forche, A., Reedy, J. L., et al. (2009) · Nature · doi:10.1038/nature08064 · Cited by 1,065 · cited 2×
“parapsilosis, Candida guilliermondii, and Candida lusitaniae are available now [149].”
BackgroundCandida Infections of Medical Devices
Kojic, E. M., & Darouiche, R. O. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.2.255-267.2004 · Cited by 1,055 · cited 1×
“From human health point of view, biofilms are important because they are developed on implanted medical devices, and it contributes to about half of all nosocomial infections [115].”
BackgroundStem cell transcriptome profiling via massive-scale mRNA sequencing
Cloonan, N., Forrest, A. R. R., Kolle, G., Gardiner, B. B. A., Faulkner, G. J., Brown, M. K., Taylor, D. F., Steptoe, A. L., Wani, S., Bethel, G., et al. (2008) · Nature Methods · doi:10.1038/nmeth.1223 · Cited by 1,035 · cited 2×
“The high-throughput technology such as Illumina IG, Applied Biosystems SOLiD, Roche 454 Life Science, andHelicos Biosciences tSMS systems are being used for a wide variety of transcriptome analysis [22–28].”
MethodThe distinct morphogenic states of Candida albicans
Sudbery, P., Gow, N., & Berman, J. (2004) · Trends in Microbiology · doi:10.1016/j.tim.2004.05.008 · Cited by 876 · cited 1×
“Among these morphological forms, the yeast-hyphae switch has been extensively studied due to its correlation with pathogenicity (Figure 1) [84].”
BackgroundHospital-Acquired Candidemia: The Attributable Mortality and Excess Length of Stay
Wey, S. B. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.1988.00380120094019 · Cited by 831 · cited 2×
“[18] S.”
BackgroundAneuploidy and Isochromosome Formation in Drug-Resistant Candida albicans
Selmecki, A., Forche, A., & Berman, J. (2006) · Science · doi:10.1126/science.1128242 · Cited by 733
Rapid transcriptome characterization for a nonmodel organism using 454 pyrosequencing
VERA, J. C., WHEAT, C. W., FESCEMYER, H. W., FRILANDER, M. J., CRAWFORD, D. L., HANSKI, I., & MARDEN, J. H. (2008) · Molecular Ecology · doi:10.1111/j.1365-294x.2008.03666.x · Cited by 714
Noble, S. M., French, S., Kohn, L. A., Chen, V., & Johnson, A. D. (2010) · Nature Genetics · doi:10.1038/ng.605 · Cited by 678
Noble, S. M., & Johnson, A. D. (2005) · Eukaryotic Cell · doi:10.1128/ec.4.2.298-309.2005 · Cited by 592 · cited 1×
“albicans, and found that there is no correlation between morphogenetic forms and virulence [106, 112].”
BackgroundCandida albicans: A molecular revolution built on lessons from budding yeast
Berman, J., & Sudbery, P. E. (2002) · Nature Reviews Genetics · doi:10.1038/nrg948 · Cited by 578 · cited 2×
“[82] J.”
BackgroundHydrolytic enzymes as virulence factors of Candida albicans
Schaller, M., Borelli, C., Korting, H. C., & Hube, B. (2005) · Mycoses · doi:10.1111/j.1439-0507.2005.01165.x · Cited by 506 · cited 1×
“The role of these SAPs in pathogenicity has been deduced from the observations that they are secreted in vivo during infection, the enzymes have the ability to degrade a number of important host factors, and the mutant strains have reduced virulence [167, 179, 180].”
BackgroundOur Current Understanding of Fungal Biofilms
Ramage, G., Mowat, E., Jones, B., Williams, C., & Lopez-Ribot, J. (2009) · Critical Reviews in Microbiology · doi:10.3109/10408410903241436 · Cited by 483 · cited 1×
“albicans is its ability to form biofilm on biotic and abiotic surfaces (as discussed above),and it is thought to be playing an important role as far as its pathogenicity is concerned [182, 183].”
BackgroundRamage, G. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf049 · Cited by 468 · cited 2×
“It has also been demonstrated that individual cells disrupted from biofilms are more resistant to the available drugs than the free-living planktonic cells [125–127].”
BackgroundSystematic Genetic Analysis of Virulence in the Human Fungal Pathogen Cryptococcus neoformans
Liu, O. W., Chun, C. D., Chow, E. D., Chen, C., Madhani, H. D., & Noble, S. M. (2008) · Cell · doi:10.1016/j.cell.2008.07.046 · Cited by 443
Adherence and receptor relationships of Candida albicans
Calderone, R. A., & Braun, P. C. (1991) · Microbiological Reviews · doi:10.1128/mr.55.1.1-20.1991 · Cited by 427 · cited 2×
“For adherence, it uses multiple mechanisms and they are well documented in the literature [168–175].”
MethodCandida albicans Als3, a multifunctional adhesin and invasin
Liu, Y., & Filler, S. G. (2011) · Eukaryotic Cell · doi:10.1128/ec.00279-10 · Cited by 354 · cited 2×
“The molecules that are responsible for adhesion are called adhesins, which include Als1p-Als7p and Asl9p, Hwp1p, Int1p, Mnt1p, and several others [176–178].”
BackgroundBiofilm Matrix Regulation by Candida albicans Zap1
Nobile, C. J., Nett, J. E., Hernday, A. D., Homann, O. R., Deneault, J.-S., Nantel, A., Andes, D. R., Johnson, A. D., & Mitchell, A. P. (2009) · PLoS Biology · doi:10.1371/journal.pbio.1000133 · Cited by 337
Ramage, G., VandeWalle, K., López-Ribot, J. L., & Wickes, B. L. (2002) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(02)00853-4 · Cited by 334
Evidence for Sexuality in the Opportunistic Fungal Pathogen Aspergillus fumigatus
Paoletti, M., Rydholm, C., Schwier, E. U., Anderson, M. J., Szakacs, G., Lutzoni, F., Debeaupuis, J.-P., Latgé, J.-P., Denning, D. W., & Dyer, P. S. (2005) · Current Biology · doi:10.1016/j.cub.2005.05.045 · Cited by 308
Role of dimorphism in the development of Candida albicans biofilms
BAILLIE, G. S., & DOUGLAS, L. J. (1999) · Journal of Medical Microbiology · doi:10.1099/00222615-48-7-671 · Cited by 304 · cited 1×
“Rather, the mutants unable to form hyphae or yeast are able to develop biofilm [122].”
BackgroundRegulation of multidrug resistance in pathogenic fungi
Morschhäuser, J. (2010) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2009.08.002 · Cited by 300 · cited 2×
“This subject has been extensively reviewed [134, 144, 145].”
BackgroundSanglard, D., Coste, A., & Ferrari, S. (2009) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2009.00578.x · Cited by 285 · cited 1×
“This subject has been extensively reviewed [134, 144, 145].”
Lickwar, C. R., Mueller, F., Hanlon, S. E., McNally, J. G., & Lieb, J. D. (2012) · Nature · doi:10.1038/nature10985 · Cited by 241
Sexual development and cryptic sexuality in fungi: insights from Aspergillus species
Dyer, P. S., & O'Gorman, C. M. (2012) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00308.x · Cited by 237 · cited 2×
“Subsequently, it has been established that this fungus is equipped with a fully functional sexual reproductive cycle, which leads to the production of cleistothecia and ascospores [205–207].”
BackgroundDunkel, N., Liu, T. T., Barker, K. S., Homayouni, R., Morschhäuser, J., & Rogers, P. D. (2008) · Eukaryotic Cell · doi:10.1128/ec.00103-08 · Cited by 236
Penetration of Candida Biofilms by Antifungal Agents
Al-Fattani, M. A., & Douglas, L. J. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.9.3291-3297.2004 · Cited by 235 · cited 1×
“However, this idea does not hold true as mutants having defective biofilm can also show high-level of drug resistance [131, 132].”
BackgroundEffect of Growth Rate on Resistance of Candida albicans Biofilms to Antifungal Agents
Baillie, G. S., & Douglas, L. J. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.8.1900 · Cited by 234
Candida albicans drug resistance—Another way to cope with stress
Cannon, R. D., Lamping, E., Holmes, A. R., Niimi, K., Tanabe, K., Niimi, M., & Monk, B. C. (2007) · Microbiology · doi:10.1099/mic.0.2007/010405-0 · Cited by 208
Mucosal biofilms of Candida albicans
Ganguly, S., & Mitchell, A. P. (2011) · Current Opinion in Microbiology · doi:10.1016/j.mib.2011.06.001 · Cited by 200 · cited 1×
“albicans is its ability to form biofilm on biotic and abiotic surfaces (as discussed above),and it is thought to be playing an important role as far as its pathogenicity is concerned [182, 183].”
BackgroundLay, J., Henry, L. K., Clifford, J., Koltin, Y., Bulawa, C. E., & Becker, J. M. (1998) · Infection and Immunity · doi:10.1128/iai.66.11.5301-5306.1998 · Cited by 174
Cramer, R. A., Perfect, B. Z., Pinchai, N., Park, S., Perlin, D. S., Asfaw, Y. G., Heitman, J., Perfect, J. R., & Steinbach, W. J. (2008) · Eukaryotic Cell · doi:10.1128/ec.00086-08 · Cited by 172
Molecular Mechanisms of Primary Resistance to Flucytosine in Candida albicans
Hope, W. W., Tabernero, L., Denning, D. W., & Anderson, M. J. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.11.4377-4386.2004 · Cited by 160 · cited 1×
“[137] W.”
Jain, R., Valiante, V., Remme, N., Docimo, T., Heinekamp, T., Hertweck, C., Gershenzon, J., Haas, H., & Brakhage, A. A. (2011) · Molecular Microbiology · doi:10.1111/j.1365-2958.2011.07778.x · Cited by 140
Kelly, S. L., Lamb, D. C., Loeffler, J., Einsele, H., & Kelly, D. E. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1136 · Cited by 116 · cited 2×
“[141] S.”
BackgroundIdentification of the Candida albicans Cap1p Regulon
Znaidi, S., Barker, K. S., Weber, S., Alarco, A.-M., Liu, T. T., Boucher, G., Rogers, P. D., & Raymond, M. (2009) · Eukaryotic Cell · doi:10.1128/ec.00002-09 · Cited by 115
Role of Ndt80p in Sterol Metabolism Regulation and Azole Resistance in Candida albicans
Sellam, A., Tebbji, F., & Nantel, A. (2009) · Eukaryotic Cell · doi:10.1128/ec.00074-09 · Cited by 91
Target specificity of the Candida albicans Efg1 regulator
Lassak, T., Schneider, E., Bussmann, M., Kurtz, D., Manak, J. R., Srikantha, T., Soll, D. R., & Ernst, J. F. (2011) · Molecular Microbiology · doi:10.1111/j.1365-2958.2011.07837.x · Cited by 76
New tools at the Candida Genome Database: biochemical pathways and full-text literature search
Skrzypek, M. S., Arnaud, M. B., Costanzo, M. C., Inglis, D. O., Shah, P., Binkley, G., Miyasato, S. R., & Sherlock, G. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp836 · Cited by 67
Efflux Pumps in Drug Resistance of Candida
Prasad, R., Gaur, N., Gaur, M., & Komath, S. (2006) · Infectious Disorders - Drug Targets · doi:10.2174/187152606784112164 · Cited by 64 · cited 1×
“This subject has been extensively reviewed [134, 144, 145].”
Cited by
Skrzypek, M. S., Binkley, J., Binkley, G., Miyasato, S. R., Simison, M., & Sherlock, G. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw924 · Cited by 455
Cinnamaldehyde and its derivatives, a novel class of antifungal agents
Shreaz, S., Wani, W. A., Behbehani, J. M., Raja, V., Irshad, M., Karched, M., Ali, I., Siddiqi, W. A., & Hun, L. T. (2016) · Fitoterapia · doi:10.1016/j.fitote.2016.05.016 · Cited by 345
Dadar, M., Tiwari, R., Karthik, K., Chakraborty, S., Shahali, Y., & Dhama, K. (2018) · Microbial Pathogenesis · doi:10.1016/j.micpath.2018.02.028 · Cited by 332
Mutua, J. K., Imathiu, S., & Owino, W. (2017) · Food Science & Nutrition · doi:10.1002/fsn3.399 · Cited by 113
“It is easy to handle and contain Candida albicans than other pathological fungi of medical importance such as Aspergillus fumigatus and Cryptococcus neoformans (Kabir et al. 2012).”
BackgroundAntifungal Activity of Plant Secondary Metabolites on Candida albicans: An Updated Review
Khan, A., Moni, S. S., Ali, M., Mohan, S., Jan, H., Rasool, S., Kamal, M. A., Alshahrani, S., Halawi, M., & Alhazmi, H. A. (2023) · Current Molecular Pharmacology · doi:10.2174/1874467215666220304143332 · Cited by 17
Metadata
- Authors
- Kabir, M. A., Hussain, M. A., & Ahmad, Z.
- Venue
- ISRN Microbiology
- Publisher
- Wiley
- Published
- 2012-09-29
- Volume
- 2012
- Pages
- 1-15
- ISSN
- 2090-7478 (ISSN-L)
- 2090-7486
- OpenAlex
- W2038843000
- Cited by
- 148
- References
- 52
- FWCI
- 3.24
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.